Triptolide derivatives for modulation of apoptosis and immunosuppression

Details for Australian Patent Application No. 2003243351 (hide)

Owner Pharmagenesis, Inc.

Inventors Lennox, Edwin S.; Musser, John H.; Dai, Dongcheng

Agent FB Rice

Pub. Number AU-B-2003243351

PCT Number PCT/US03/17177

PCT Pub. Number WO2003/101951

Priority 60/384,480 31.05.02 US

Filing date 29 May 2003

Wipo publication date 19 December 2003

Acceptance publication date 30 April 2009

International Classifications

A61K 31/365 (2006.01) - Lactones

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

C07D 493/22 (2006.01) Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system

Event Publications

11 September 2003 Complete Application Filed

  Priority application(s): 60/384,480 31.05.02 US

12 February 2004 Application Open to Public Inspection

  Published as AU-B-2003243351

30 April 2009 Application Accepted

  Published as AU-B-2003243351

27 August 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003243352-TECHNIQUE TO IMPROVE NETWORK ROUTING USING BESTMATCH AND EXACT-MATCH TECHNIQUES

2003243350-COMPARATIVE PROTEOMICS OF PROGRESSOR AND NONPROGRESSOR POPULATIONS